Neurogene Inc (NGNE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | ||
| Net Income | -1,010 | -7,710 |
| Depreciation Amortization | 40 | 170 |
| Other Working Capital | 48 | -40 |
| Other Operating Activity | 26 | 350 |
| Operating Cash Flow | $-897 | $-7,230 |
| Cash Flows From Investing Activities | ||
| PPE Investments | 46 | -6 |
| Investing Cash Flow | $46 | $-6 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 17,867 | 0 |
| Financing Cash Flow | $17,867 | $0 |
| Beginning Cash Position | 2,001 | 9,230 |
| End Cash Position | 19,017 | 2,000 |
| Net Cash Flow | $17,017 | $-7,230 |
| Free Cash Flow | ||
| Operating Cash Flow | -897 | -7,230 |
| Capital Expenditure | -5 | N/A |
| Free Cash Flow | -901 | -7,230 |